AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 60(2), 1999, pp. 238-243
Copyright © 1999 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Looareesuwan, S
Right arrow Articles by Royce, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Looareesuwan, S
Right arrow Articles by Royce, C
Related Collections
Right arrow Plasmodium
Right arrow Health Outcomes
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 60, Issue 2, 238-243
Copyright © 1999 by American Society of Tropical Medicine and Hygiene

Research Articles


A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand

S Looareesuwan, P Wilairatana, W Chokejindachai, K Chalermrut, W Wernsdorfer, B Gemperli, I Gathmann, and C Royce

CGP 56697, a new oral fixed combination of artemether and benflumetol, was tested in a double-blinded, randomized trial in 252 adult patients treated either with CGP 56697 (4 x 4 tablets each containing 20 mg of artemether and 120 mg of benflumetol, given at 0, 8, 24, and 48 hr), or with mefloquine (three tablets of 250 mg at initial diagnosis, followed by two tablets of 250 mg at 8 hr). Baseline data of the two groups were comparable. The 28-day cure rate with CGP 56697 was lower than with mefloquine (69.3% versus 82.4%; P = 0.002). However, CGP 56697 was more effective than mefloquine in parasite clearance time (43 hr versus 66 hr; P < 0.001) fever clearance time (32 hr versus 54 hr; P < 0.005), and gametocyte clearance time (152 hr versus 331 hr; P < 0.001). This study revealed that CGP 56697 is effective against multidrug-resistant Plasmodium falciparum malaria in Thailand, but higher doses will probably be needed to improve the cure rate.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
I. SAGARA, A. DICKO, A. DJIMDE, O. GUINDO, M. KONE, Y. TOLO, M. A. THERA, M. SOGOBA, M. FOFANA, A. OUATTARA, et al.
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in mali.
Am J Trop Med Hyg, October 1, 2006; 75(4): 630 - 636.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. G. ALECRIM, M. V. LACERDA, M. P. MOURAO, W. D. ALECRIM, A. PADILHA, B. S. CARDOSO, and M. BOULOS
SUCCESSFUL TREATMENT OF PLASMODIUM FALCIPARUM MALARIA WITH A SIX-DOSE REGIMEN OF ARTEMETHER-LUMEFANTRINE VERSUS QUININE-DOXYCYCLINE IN THE WESTERN AMAZON REGION OF BRAZIL
Am J Trop Med Hyg, January 1, 2006; 74(1): 20 - 25.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. V. Pandey, B. L. Tekwani, R. L. Singh, and V. S. Chauhan
Artemisinin, an Endoperoxide Antimalarial, Disrupts the Hemoglobin Catabolism and Heme Detoxification Systems in Malarial Parasite
J. Biol. Chem., July 2, 1999; 274(27): 19383 - 19388.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society of Tropical Medicine and Hygiene.